Bionano Genomics, Inc. (BNGO)
1.215
+0.02
(+1.25%)
USD |
NASDAQ |
Sep 09, 11:41
Bionano Genomics Total Assets (Quarterly) : 47.59M for June 30, 2026
Total Assets (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Total Assets (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 47.59M |
| March 31, 2026 | 64.80M |
| December 31, 2025 | 73.58M |
| September 30, 2025 | 79.06M |
| June 30, 2025 | 76.01M |
| March 31, 2025 | 78.41M |
| December 31, 2024 | 76.67M |
| September 30, 2024 | 87.36M |
| June 30, 2024 | 129.36M |
| March 31, 2024 | 158.00M |
| December 31, 2023 | 214.40M |
| September 30, 2023 | 181.90M |
| June 30, 2023 | 271.38M |
| March 31, 2023 | 292.15M |
| December 31, 2022 | 307.50M |
| September 30, 2022 | 323.70M |
| June 30, 2022 | 321.55M |
| Date | Value |
|---|---|
| March 31, 2022 | 348.21M |
| December 31, 2021 | 377.10M |
| September 30, 2021 | 359.66M |
| June 30, 2021 | 356.81M |
| March 31, 2021 | 384.86M |
| December 31, 2020 | 60.45M |
| September 30, 2020 | 41.40M |
| June 30, 2020 | 27.20M |
| March 31, 2020 | 19.10M |
| December 31, 2019 | 30.21M |
| September 30, 2019 | 19.21M |
| June 30, 2019 | 25.21M |
| March 31, 2019 | 29.55M |
| December 31, 2018 | 24.80M |
| September 30, 2018 | 30.67M |
| June 30, 2018 | 18.09M |
| March 31, 2018 | 16.46M |
Total Assets Definition
Assets are a main portion of the balance sheet of a company that measure things that provide economic value. A few examples of assets of a company include cash, inventories, and accounts receivable. From an accounting perspective, the balance sheet equation is Assets = Liabilities + Shareholder's Equity.
Total Assets (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Assets (Quarterly) Benchmarks
| Agilent Technologies, Inc. | 13.97B |
| Bio-Rad Laboratories, Inc. | 10.25B |
| Bruker Corp. | 6.053B |
| Danaher Corp. | 92.37B |
| Harvard Bioscience, Inc. | 76.29M |
Total Assets (Quarterly) Related Metrics
| Total Liabilities (Quarterly) | 15.98M |
| Shareholders Equity (Quarterly) | 31.61M |
| Debt to Equity Ratio | 0.2121 |
| Current Ratio | 2.478 |
| Net Debt Paydown Yield | 17.60% |